Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Amgen Inc (AMGN)

Amgen Inc (AMGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 166,707,904
  • Shares Outstanding, K 536,435
  • Annual Sales, $ 28,190 M
  • Annual Income, $ 6,717 M
  • 60-Month Beta 0.58
  • Price/Sales 5.95
  • Price/Cash Flow 11.85
  • Price/Book 33.38
Trade AMGN with:

Options Overview Details

View History
  • Implied Volatility 20.15% ( -0.91%)
  • Historical Volatility 17.72%
  • IV Percentile 33%
  • IV Rank 21.89%
  • IV High 33.07% on 04/16/24
  • IV Low 16.53% on 09/01/23
  • Put/Call Vol Ratio 0.69
  • Today's Volume 3,969
  • Volume Avg (30-Day) 8,520
  • Put/Call OI Ratio 0.92
  • Today's Open Interest 169,559
  • Open Int (30-Day) 185,203

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 25 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate 4.86
  • Number of Estimates 12
  • High Estimate 5.12
  • Low Estimate 4.46
  • Prior Year 5.00
  • Growth Rate Est. (year over year) -2.80%

Price Performance

See More
Period Period Low Period High Performance
1-Month
295.30 +4.77%
on 06/13/24
326.12 -5.13%
on 06/25/24
+1.96 (+0.64%)
since 06/03/24
3-Month
260.68 +18.68%
on 04/19/24
326.12 -5.13%
on 06/25/24
+34.96 (+12.74%)
since 04/03/24
52-Week
218.44 +41.63%
on 07/07/23
329.72 -6.17%
on 02/05/24
+84.37 (+37.50%)
since 07/03/23

Most Recent Stories

More News
1 Dividend Growth Stock to Buy and Hold for 10 Years

This company's payouts look safe.

AMGN : 309.38 (-0.45%)
Can Amgen Stock Keep Trouncing the S&P 500?

Amgen's market-beating ways are unlikely to evaporate any time soon.

AMGN : 309.38 (-0.45%)
Biotechs Race to Develop New Treatments as Global Pancreatic Cancer Market Size Expected to Reach $7.5 Billion by 2033

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:KYMR),(NASDAQ:GILD),(OTCQX:RHHBY),(NASDAQ:AMGN) EQNX::TICKER_END

ONCY : 0.9807 (-0.94%)
ONC.TO : 1.38 (+0.73%)
KYMR : 30.35 (+0.43%)
RHHBY : 34.1100 (-0.93%)
GILD : 66.50 (-2.78%)
AMGN : 309.38 (-0.45%)
Biotechs Race to Develop New Treatments as Global Pancreatic Cancer Market Size Expected to Reach $7.5 Billion by 2033

ONCY : 0.9807 (-0.94%)
ONC.TO : 1.38 (+0.73%)
KYMR : 30.35 (+0.43%)
RHHBY : 34.1100 (-0.93%)
GILD : 66.50 (-2.78%)
AMGN : 309.38 (-0.45%)
Where Will Amgen Be in 5 Years?

Can Amgen be a market-beating stock?

LLY : 896.86 (-1.09%)
AMGN : 309.38 (-0.45%)
Is Gilead Sciences Stock Underperforming the Nasdaq?

Gilead Sciences has recently underperformed the broader Nasdaq Composite, but analysts are reasonably bullish about the stock’s outlook.

GILD : 66.50 (-2.78%)
$NASX : 18,188.30 (+0.88%)
AMGN : 309.38 (-0.45%)
How Is Regeneron Pharmaceuticals' Stock Performance Compared to Other Biotechnology Stocks?

Regeneron Pharmaceuticals has outperformed the broader market over the past year, and Wall Street analysts are optimistic about the stock’s outlook.

REGN : 1,023.90 (-1.99%)
IBB : 135.09 (-0.68%)
AMGN : 309.38 (-0.45%)
Is Amgen Stock Outperforming the S&P 500?

Amgen has outperformed the S&P 500, and analysts remain optimistic about the stock’s prospects because of the positive Phase 2 clinical trial data of its obesity drug MariTide.

AMGN : 309.38 (-0.45%)
$SPX : 5,537.02 (+0.51%)
LLY : 896.86 (-1.09%)
NVO : 138.50 (-3.13%)
BIIB : 224.61 (-1.84%)
Is Geron Stock a Buy Following Its First New Drug Approval?

Find out if the high-flying biotech stock can keep on climbing higher.

AMGN : 309.38 (-0.45%)
GERN : 4.36 (+4.56%)
Is Abbvie Stock Underperforming the S&P 500?

Despite headwinds from Humira patent expiry, potential price controls from the Inflation Reduction Act, and recent underperformance relative to the S&P 500, Wall Street analysts anticipate moderate gains...

ABBV : 164.25 (-1.03%)
AMGN : 309.38 (-0.45%)
$SPX : 5,537.02 (+0.51%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Amgen Inc. is the leading biotech companies world wide, with a strong presence in the oncology/hematology, cardiovascular disease, neuroscience, inflammation, bone health & nephrology and neuroscience markets. It developed two most successful drugs, Epogen & Neupogen. Amgen successfully launched two...

See More

Key Turning Points

3rd Resistance Point 319.01
2nd Resistance Point 315.77
1st Resistance Point 312.58
Last Price 309.38
1st Support Level 306.15
2nd Support Level 302.91
3rd Support Level 299.72

See More

52-Week High 329.72
Last Price 309.38
Fibonacci 61.8% 287.21
Fibonacci 50% 274.08
Fibonacci 38.2% 260.95
52-Week Low 218.44

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar